News Summary

Following the bankruptcy filing of biotechnology company 23andMe, the House Committee on Energy and Commerce is investigating the company’s handling of sensitive customer data. Concerns have arisen regarding the management of customer information, particularly in light of the company’s Chapter 11 filing and the resignation of co-founder and CEO Anne Wojcicki, who intends to become a private bidder for the company. The investigation addresses issues such as the potential sale of customer data and the lack of HIPAA protections for direct-to-consumer genetic testing companies. With 23andMe’s previous settlement of a data breach lawsuit, the handling of sensitive genetic information remains a significant concern.